monoclonal antibody HuM195
Term · Oncology and biomedicine · MLC-T-ONC-005489
A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Monoclonal antibody HuM195 is a type of monoclonal antibody. Also called lintuzumab and MoAb HuM195.
| Identifier | MLC-T-ONC-005489 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | lintuzumab; MoAb HuM195 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005489",
"term": "monoclonal antibody HuM195",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Monoclonal antibody HuM195 is a type of monoclonal antibody. Also called lintuzumab and MoAb HuM195.",
"synonyms": [
"lintuzumab",
"MoAb HuM195"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/monoclonal-antibody-hum195/"
}
Record 11,244 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.